Blood Pressure Monitor (TH-75) Atrial Fibrillation Detection Function Clinical Trial

This study evaluates the accuracy of a blood pressure monitor in detecting atrial fibrillation by comparing its results with a standard diagnostic method.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Atrial Fibrillation (AF) Arrhythmias, Cardiac Atrial Fibrillation Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Tianjin, Tianjin Municipality, 300381, China

Location status: Recruiting

Location contact

Tianqing Ni

CONTACT

[email protected]

022-27986255

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Atrial Fibrillation (AF):

Age ≥ 22 years;
Arm circumference between 22 cm and 42 cm;
Diagnosed with atrial fibrillation by a qualified medical institution.

Non-Atrial Fibrillation:

Age ≥ 22 years;
Arm circumference between 22 cm and 42 cm;
No prior diagnosis of atrial fibrillation.

Exclusion criteria

Pregnant women
Presence of an implanted cardiac pacemaker and/or defibrillator
Inability to cooperate with blood pressure measurement or ECG assessment
Any condition that, in the opinion of the investigator, makes the participant unsuitable for participation in this clinical study

Treatment and study plan

Primary outcomes

Accuracy of atrial fibrillation detection by the TH-75 blood pressure monitor, assessed against the prespecified acceptance criteria.

Time frame: Baseline

Study contacts

Contact information is provided by the study sponsor or research team.

Jing Li

CONTACT

[email protected]

022-87611660

Sponsors and collaborators

Lead sponsor

Andon Health Co., Ltd

Industry

Collaborators

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

Registry information

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Mar 2, 2026
Registry last updated: Mar 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting